National Observatory of Bacterial Meningitis in Children and Newborns

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

Bacterial meningitis is a major cause of morbidity and mortality in childhood. Antibiotic treatment recommendations are based on epidemiological and susceptibility data. The epidemiology of bacterialméningitis has changed in recent years, mainly owing to widespread use of different conjugate vaccines. The aim of this prospective national survey is to describe epidemiology of bacteria implicated in bacterial meningitis in children.

Eligibility
Participation Requirements
Sex: All
Maximum Age: 18
View:

• clinical signs of meningitis, associated with positive cerebrospinal fluid (CSF) culture and/or positive CSF antigen testing (Escherichia coli K1, N. meningitidis serogroups B, A, C, Y and W-135, group B streptococci, Hib, or S. pneumoniae), and/or positive CSF polymerase chain reaction (PCR), and/or positive blood culture with CSF pleocytosis (\> 10 cells/µL).

• purpura fulminans

Locations
Other Locations
France
ACTIV
RECRUITING
Créteil
Contact Information
Primary
Corinne Levy, MD
corinne.levy@activ-france.fr
0033148850404
Time Frame
Start Date: 2001-01-01
Estimated Completion Date: 2030-01-01
Participants
Target number of participants: 8230
Treatments
Cohort of bacterial meningitis in children
Related Therapeutic Areas
Sponsors
Leads: Association Clinique Thérapeutique Infantile du val de Marne
Collaborators: Pfizer

This content was sourced from clinicaltrials.gov